drugset / Trial / NCT01840813

Intraumbilical Misoprostol in Retained Placenta

NCT01840813

Phase 1 Completed 46 enrolled Hawler Medical University
Non-randomizedParallel-groupOpen-labelTreatment

Summary

Administration of intraumbilical misoprostol to women with retained placenta despite active management of third stage of labour reduces the need for manual removal of placenta and the amount of blood loss vaginally.

Timeline

Start
2011-04
Primary completion
2012-03
Completion
2012-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Misoprostol Other / unclassified 800 ug Other

Indications